Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cryptococcal Antigenemia in Human Immunodeficiency Virus Antiretroviral Therapy-Experienced Ugandans With Virologic Failure.
Mpoza E, Rajasingham R, Tugume L, Rhein J, Nabaggala MS, Ssewanyana I, Nyegenye W, Kushemererwa GE, Mulema V, Kalamya J, Kiyaga C, Kabanda J, Ssali M, Boulware DR, Meya DB. Mpoza E, et al. Among authors: nabaggala ms. Clin Infect Dis. 2020 Oct 23;71(7):1726-1731. doi: 10.1093/cid/ciz1069. Clin Infect Dis. 2020. PMID: 31679007 Free PMC article.
An observational study in an urban Ugandan clinic comparing virological outcomes of patients switched from first-line antiretroviral regimens to second-line regimens containing ritonavir-boosted atazanavir or ritonavir-boosted lopinavir.
Laker EAO, Nabaggala MS, Kaimal A, Nalwanga D, Castelnuovo B, Musubire A, Kiragga A, Lamorde M, Ratanshi RP. Laker EAO, et al. Among authors: nabaggala ms. BMC Infect Dis. 2019 Mar 25;19(1):280. doi: 10.1186/s12879-019-3907-5. BMC Infect Dis. 2019. PMID: 30909871 Free PMC article.
Significant rates of risky sexual behaviours among HIV-infected patients failing first-line ART: A sub-study of the Europe-Africa Research Network for the Evaluation of Second-line Therapy trial.
Wanyama JN, Nabaggala MS, Wandera B, Kiragga AN, Castelnuovo B, Mambule IK, Nakajubi J, Kambugu AD, Paton NI, Wanyenze RK, Colebunders R, Easterbrook P. Wanyama JN, et al. Among authors: nabaggala ms. Int J STD AIDS. 2018 Mar;29(3):287-297. doi: 10.1177/0956462417724707. Epub 2017 Aug 17. Int J STD AIDS. 2018. PMID: 28814161
Re-engagement in HIV care following a missed visit in rural Uganda.
Nabaggala MS, Parkes-Ratanshi R, Kasirye R, Kiragga A, Castlenuovo B, Ochaka I, Nakakawa L, Bena DA, Mujugira A. Nabaggala MS, et al. BMC Res Notes. 2018 Oct 25;11(1):762. doi: 10.1186/s13104-018-3865-9. BMC Res Notes. 2018. PMID: 30359290 Free PMC article.
An Interactive Voice Response Software to Improve the Quality of Life of People Living With HIV in Uganda: Randomized Controlled Trial.
Byonanebye DM, Nabaggala MS, Naggirinya AB, Lamorde M, Oseku E, King R, Owarwo N, Laker E, Orama R, Castelnuovo B, Kiragga A, Parkes-Ratanshi R. Byonanebye DM, et al. Among authors: nabaggala ms. JMIR Mhealth Uhealth. 2021 Feb 11;9(2):e22229. doi: 10.2196/22229. JMIR Mhealth Uhealth. 2021. PMID: 33570497 Free PMC article. Clinical Trial.
Acceptability of a Mobile Phone Support Tool (Call for Life Uganda) for Promoting Adherence to Antiretroviral Therapy Among Young Adults in a Randomized Controlled Trial: Exploratory Qualitative Study.
Twimukye A, Bwanika Naggirinya A, Parkes-Ratanshi R, Kasirye R, Kiragga A, Castelnuovo B, Wasswa J, Nabaggala MS, Katabira E, Lamorde M, King RL. Twimukye A, et al. Among authors: nabaggala ms. JMIR Mhealth Uhealth. 2021 Jun 14;9(6):e17418. doi: 10.2196/17418. JMIR Mhealth Uhealth. 2021. PMID: 34121665 Free PMC article. Clinical Trial.
Effect of HIV Self-Testing on PrEP Adherence Among Gender-Diverse Sex Workers in Uganda: A Randomized Trial.
Mujugira A, Nakyanzi A, Nabaggala MS, Muwonge TR, Ssebuliba T, Bagaya M, Nampewo O, Sapiri O, Nyanzi KR, Bambia F, Nsubuga R, Serwadda DM, Ware NC, Baeten JM, Haberer JE. Mujugira A, et al. Among authors: nabaggala ms. J Acquir Immune Defic Syndr. 2022 Apr 1;89(4):381-389. doi: 10.1097/QAI.0000000000002895. J Acquir Immune Defic Syndr. 2022. PMID: 34954718 Free PMC article. Clinical Trial.
Willingness to pay for an mHealth anti-retroviral therapy adherence and information tool: Transitioning to sustainability, Call for life randomised study experience in Uganda.
Naggirinya AB, Kyomugisha EL, Nabaggala MS, Nasasira B, Akirana J, Oseku E, Kiragga A, Castelnuovo B, King RL, Katabira E, Byonanebye DM, Lamorde M, Parkes-Ratanshi R. Naggirinya AB, et al. Among authors: nabaggala ms. BMC Med Inform Decis Mak. 2022 Feb 26;22(1):52. doi: 10.1186/s12911-022-01782-0. BMC Med Inform Decis Mak. 2022. PMID: 35219309 Free PMC article. Clinical Trial.
22 results